Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ImmunoGen, a biopharmaceutical company, has appointed Gregory Perry as its new senior vice president and CFO. Mr Perry succeeds Daniel Junius, who had been the company's CFO prior to his promotion.
Subscribe to our email newsletter
Before joining ImmunoGen, Mr Perry was CFO of Elixir Pharmaceuticals, where he was extensively involved in partnering and fundraising activities. Prior to Elixir, he was CFO of Domantis, an antibody-related therapeutics company.
Daniel Junius, president and CEO of ImmunoGen, said: “Greg is an excellent addition to our management team, as he has extensive financial expertise and an impressive record of building value at healthcare-focused companies. We believe Greg’s depth of experience is particularly valuable in light of our growing portfolio of advancing anticancer compounds.”